Phillip Sharp

Phillip Sharp
Name	Phillip Sharp
Birth date	June 6, 1944
Birth place	Falmouth, Massachusetts, United States
Nationality	American
Fields	Molecular biology, Genetics, Biochemistry
Institutions	Massachusetts Institute of Technology, Cold Spring Harbor Laboratory, Biogen
Alma mater	Yale University, University of Illinois at Urbana–Champaign
Known for	Discovery of RNA splicing, work on gene structure
Awards	Nobel Prize in Physiology or Medicine, National Medal of Science, Lasker Award

Phillip Sharp (born June 6, 1944) is an American molecular biologist and geneticist noted for the discovery of RNA splicing and contributions to understanding eukaryotic gene structure and regulation. His work at institutions such as Cold Spring Harbor Laboratory and the Massachusetts Institute of Technology reshaped concepts in molecular biology and influenced biotechnology companies like Biogen. Sharp's research and leadership earned major honors including the Nobel Prize in Physiology or Medicine and the National Medal of Science.

Early life and education

Sharp was born in Falmouth, Massachusetts, and raised in Hyde Park, Massachusetts and Falmouth, Massachusetts. He attended Yale University where he studied chemistry and biology, interacting with faculty in departments led by figures associated with Oswald Avery-era transformation studies and the postwar expansion of molecular biology. After Yale, Sharp pursued graduate studies at the University of Illinois at Urbana–Champaign under advisors working in bacterial genetics and virology, engaging with research communities connected to Salvador Luria-influenced bacteriophage studies and the lineage of Max Delbrück. His doctoral work prepared him for postdoctoral training in laboratories that intersected with researchers from Cold Spring Harbor Laboratory and the emerging centers of recombinant DNA research such as Stanford University and Harvard University.

Scientific career and research

Sharp established his independent laboratory at Cold Spring Harbor Laboratory and later joined the faculty of the Massachusetts Institute of Technology, where he became a central figure in studies of gene architecture. In the early 1970s his group discovered that precursor messenger RNA transcripts in higher eukaryotes are cleaved and ligated through a process now known as RNA splicing, overturning prevailing models derived from Francis Crick-influenced linear gene concepts and earlier work by investigators at Max Planck Society-affiliated institutes. This finding connected to prior observations from groups at University of California, Berkeley and Imperial Cancer Research Fund laboratories, and prompted new investigations into spliceosomal components including small nuclear ribonucleoproteins characterized by researchers at National Institutes of Health laboratories.

Sharp's lab elucidated mechanisms by which introns and exons are recognized, collaborating with and influencing scientists from Cold Spring Harbor Laboratory, Harvard Medical School, University of California, San Francisco, and biotechnology firms such as Genentech. His studies integrated approaches from enzymology established by researchers at Max Planck Institute for Biophysical Chemistry and structural insights emerging from teams at European Molecular Biology Laboratory. The discovery of alternative splicing in his and parallel groups’ work aligned with functional studies by groups at Johns Hopkins University and University of California, San Diego, showing how single genes produce multiple protein isoforms, with implications for developmental pathways studied in model organisms like Drosophila melanogaster and Caenorhabditis elegans.

Throughout his career Sharp contributed to translational initiatives linking academic research with industry, advising or co-founding ventures and consulting for entities including Biogen and interactions with the Whitehead Institute. His publications and collaborative projects crossed institutional boundaries involving Cold Spring Harbor Laboratory, MIT Koch Institute for Integrative Cancer Research, and international centers such as Institut Pasteur.

Nobel Prize and major awards

In 1993 Sharp shared the Nobel Prize in Physiology or Medicine with Richard J. Roberts for the discovery of split genes and the biological phenomenon of introns and RNA splicing. The award followed a sequence of honors including the Albert Lasker Basic Medical Research Award and the National Medal of Science presented by the President of the United States. Sharp received honorary degrees and fellowships from institutions such as Harvard University, Yale University, and societies like the National Academy of Sciences, the American Academy of Arts and Sciences, and international academies including the Royal Society and the European Molecular Biology Organization. His recognition also included awards from foundations and organizations such as the Gairdner Foundation and the Wolf Foundation.

Academic leadership and teaching

At the Massachusetts Institute of Technology, Sharp served as Institute Professor and as founding director of initiatives that bridged basic research with clinical and industrial translation, working with leadership at the MIT Department of Biology, the MIT Center for Cancer Research, and cross-disciplinary programs affiliated with the Whitehead Institute for Biomedical Research. He mentored a generation of scientists who went on to faculty positions at Harvard Medical School, Stanford University, University of California, San Francisco, and other major research centers, and his trainees established labs that contributed to genetics, oncology, and biotechnology sectors, including companies like Genentech and Biogen Idec spin-offs. Sharp taught courses and seminars that drew students from MIT School of Science and collaborated on curriculum initiatives with colleagues at Cold Spring Harbor Laboratory and the Broad Institute.

Beyond teaching, he participated in advisory roles for funding agencies including the National Institutes of Health, served on boards for research institutes such as Cold Spring Harbor Laboratory and corporate boards in biotechnology, and engaged in science policy discussions linked to organizations like the National Science Foundation.

Personal life and legacy

Sharp is married and has family ties to communities in the Boston, Massachusetts area, maintaining connections to institutions across the United States and internationally. His legacy includes the paradigm shift in understanding gene organization that underpins modern molecular genetics, genomics projects at centers like the Human Genome Project, therapeutic strategies developed by companies such as Genentech and Biogen, and ongoing research in RNA biology pursued at laboratories including Cold Spring Harbor Laboratory and MIT. Monographs, reviews, and retrospectives in journals associated with societies like the American Association for the Advancement of Science and archives at institutions including Yale University document his scientific contributions and mentorship.

Category:American molecular biologists Category:Nobel laureates in Physiology or Medicine